Brazil’s Vaccination Push: A Look at Yellow Fever and Measles, and What It Signals for Global Health
Recent health initiatives in São Paulo, Brazil, are highlighting the ongoing need for vigilance against preventable diseases like yellow fever and measles. A renewed focus on vaccination, particularly for those who received a fractional dose of the yellow fever vaccine in 2018, and a campaign to bolster measles immunity, offers a crucial case study in public health preparedness and the evolving landscape of infectious disease control.
The Yellow Fever Catch-Up: Why a Second Dose Matters
In 2018, Brazil faced a significant yellow fever outbreak, prompting a temporary strategy of fractional doses – administering a smaller amount of vaccine to stretch limited supplies. A study by the Fiocruz Foundation revealed that this fractional approach provided protection equivalent to a full dose for at least eight years. Now, those who received that fractional dose are being urged to get a booster shot. This isn’t a sign of the initial strategy failing, but a testament to the understanding that immunity wanes over time, and proactive boosting is essential.
As of 2025, São Paulo state alone has confirmed 57 cases of yellow fever, resulting in 34 fatalities. This underscores the continued risk, even in areas with previous vaccination efforts. The situation mirrors challenges faced in other tropical regions globally, where climate change and deforestation are expanding the range of mosquito vectors carrying the virus.
Pro Tip: Don’t rely on memory! If you’re unsure whether you received a full or fractional dose of the yellow fever vaccine in 2018, visit your local health clinic (UBS) to check your vaccination records and receive appropriate guidance.
Measles Resurgence: A Global Warning
Alongside the yellow fever campaign, Brazil is actively reinforcing measles vaccination. While the country regained its “measles-free” status in 2024 after losing it in 2019, the threat remains real. The United States and other nations are currently experiencing significant measles outbreaks, demonstrating how quickly the disease can re-emerge with declining vaccination rates.
In 2025, São Paulo registered two imported cases of measles, highlighting the risk posed by international travel. The state’s major airports and ports serve as potential entry points for the virus, making widespread vaccination even more critical, especially for those in tourism and transportation sectors.
Future Trends in Vaccination Strategies
The Brazilian experience points to several key trends shaping the future of vaccination programs worldwide:
- Adaptive Vaccination Strategies: The 2018 yellow fever response demonstrates the need for flexibility. Public health officials must be prepared to adapt vaccination strategies based on disease outbreaks, vaccine availability, and evolving scientific understanding.
- Boosters and Waning Immunity: Increasingly, we’re recognizing that immunity from many vaccines isn’t lifelong. Regular booster shots will become more commonplace to maintain protection against diseases like yellow fever, measles, and even COVID-19.
- Targeted Vaccination: Focusing vaccination efforts on high-risk groups – travelers, healthcare workers, and communities with low vaccination rates – will be crucial for maximizing impact and resource allocation.
- Combating Vaccine Hesitancy: Addressing misinformation and building public trust in vaccines remains a significant challenge. Effective communication strategies and community engagement are essential.
- Enhanced Surveillance: Robust disease surveillance systems are vital for early detection of outbreaks and rapid response. Investing in laboratory capacity and data analysis is paramount.
Did you know? Measles is one of the most contagious diseases known to humankind. 95% vaccination coverage is needed to achieve herd immunity and prevent outbreaks.
Who Needs to Be Vaccinated? (Current Recommendations)
Yellow Fever:
- Individuals vaccinated with a fractional dose in 2018.
- Children: One dose at 9 months, with a booster at 4 years.
- Those who received only one dose before age 5 should get a booster.
- Individuals aged 5-59 who haven’t been vaccinated should receive a single dose.
Measles:
- Children: First dose at 12 months (MMR), second at 15 months (MMRV).
- Individuals aged 5-29: Two doses, at least 30 days apart.
- Individuals aged 30-59: One dose.
- Healthcare workers: Two doses of MMR, depending on vaccination status.
FAQ
- Q: Is the yellow fever vaccine safe?
A: Yes, the yellow fever vaccine is generally safe and highly effective. Mild side effects, such as fever and muscle aches, are common. - Q: Can I get the yellow fever vaccine if I have allergies?
A: Individuals with severe allergies to egg proteins should consult with their doctor before receiving the vaccine. - Q: Where can I find a vaccination clinic?
A: Contact your local health department (UBS in Brazil) or visit the Ministry of Health website for a list of vaccination sites. - Q: What if I’ve already had measles?
A: Even if you’ve had measles, vaccination is still recommended to ensure long-lasting immunity.
Staying informed and proactive about vaccination is a critical step in protecting yourself and your community. Explore the resources provided by the Ministry of Health and your local health authorities to learn more and schedule your vaccinations today.
Keep reading